Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma
Neuro-Oncology · 2025
DOI: 10.1093/neuonc/noaf145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Qing You Pang und 21 weiteren Autor:innen. Beteiligte Einrichtung: Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience Institute, Singapore 308433, Singapore. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Epithelial-Mesenchymal Transition, Transcriptome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Singapore Ministry of Health's National Medical Research Council, National Research Foundation Singapore, Singapore Ministry of Health’s National Medical Research Council.
Abstract (Originalsprache)
Background
Multi-omics profiling of glioblastoma (GBM) has unraveled two aspects fundamental to its aggressiveness and lethality that is molecular heterogeneity inherent to the tumor and cellular plasticity modulated by the microenvironment. Yet, empirical validation to identify causal factors for these complex mechanisms is rather scarce. Here, we report our endeavor in establishing Glioportal, a GBM tumor biobank with derivative preclinical models and molecular information that we leverage for basic and translational research on precision therapies.
Methods
Bulk transcriptome and single-cell-based deconvolution analyses highlighted key features of distinct GBM subtypes and ligand-receptor pairs predicted to regulate malignant cell state plasticity. Synthetic genetic tracing tool and target genes/proteins expression analyses validated ligands-induced mesenchymal transition. This was further corroborated with phenotypic invasion/migration assays and cell-based assays using inhibitors, functional antibodies, and gene silencing approaches. A proof-of-concept animal experiment was conducted using orthotopic xenograft carrying gene knockdown. Clinical relevance was assessed through immunohistochemical assay.
Results
Our transcriptomic analysis highlights the integral roles of STAT3 and NF-κB pathways in maintaining intrinsic mesenchymal identity and enabling myeloid-induced plasticity towards mesenchymal phenotype. One critical ligand, TNF, confers mesenchymal adaptation and cellular invasiveness that is mitigated by TNFRSF1A, but not TNFRSF1B, loss of function. TNFRSF1A silencing significantly improves survival in vivo.
Conclusion
Glioportal makes a valuable resource for identifying therapeutic vulnerabilities in molecularly stratified GBM. Here, we underscore GBM dependency on myeloid-derived ligands to acquire mesenchymal traits that have clinical implications in therapeutic response and recurrence. Such reliance warrants treatment strategies targeting ligand-receptor pairs to mitigate interactions with the tumor ecosystem.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience Institute, Singapore 308433, Singapore.
- Laboratory of Computational Cancer Genomics, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore 138672, Singapore.
- Laboratory of Single-Cell Spatial Neuromics, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore 138672, Singapore.
- Department of Neurology, National Neuroscience Institute, Singapore 308433, Singapore.
- SingHealth Duke-NUS Neuroscience Academic Clinical Programme, Duke-National University of Singapore Medical School, Singapore 169857, Singapore.
- Department of Neurosurgery, National Neuroscience Institute, Singapore 308433, Singapore.
ORCID-Profile: Marija Cvijovic, Wilson Wen Bin Goh, Nguan Soon Tan, Stephen Yip
Förderung
- Singapore Ministry of Health's National Medical Research Council
- National Research Foundation Singapore
- Singapore Ministry of Health’s National Medical Research Council
Zitieren
APA
Pang, Q. Y., Novera, W., Koh, L. W. H., Chong, Y. K., Lim, S. W., Sim, N. L., Rizzetto, S., Liu, J., Lin, X., Ang, S. Y. L., Ker, J. R., Wan, K. R., Low, D. C. Y., Cvijovic, M., Goh, W. W. B., Shao, H., Tan, N. S., Yip, S., Skanderup, A. M. J., …, & Ang, B. T. (2025). Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf145
Vancouver
Pang QY, Novera W, Koh LWH, Chong YK, Lim SW, Sim NL, et al. Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf145
BibTeX
@article{Pang2025,
author = {Pang, Qing You and Novera, Wisna and Koh, Lynnette Wei Hsien and Chong, Yuk Kien and Lim, See Wee and Sim, Ngak Leng and Rizzetto, Simone and Liu, Jinyue and Lin, Xuling and Ang, Samantha Ya Lyn and Ker, Justin Rui-Xin and Wan, Kai-Rui and Low, David Chyi Yeu and Cvijovic, Marija and Goh, Wilson Wen Bin and Shao, Huilin and Tan, Nguan Soon and Yip, Stephen and Skanderup, Anders Martin Jacobsen and Tang, Carol and Tan, Patrick and Ang, Beng Ti},
title = {Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma},
journal = {Neuro-Oncology},
year = {2025},
doi = {10.1093/neuonc/noaf145}
}
EUVIMED